Aura Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AURA and other ETFs, options, and stocks.About AURA
Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities.
AURA Key Statistics
Stock Snapshot
Aura Biosciences(AURA) stock is priced at $8.55, giving the company a market capitalization of 572.66M. It carries a P/E multiple of -4.91.
As of 2026-05-06, Aura Biosciences(AURA) stock has fluctuated between $8.43 and $9.54. The current price stands at $8.55, placing the stock +1.4% above today's low and -10.4% off the high.
Aura Biosciences(AURA) shares are trading with a volume of 5.88M, against a daily average of 946.92K.
During the past year, Aura Biosciences(AURA) stock moved between $4.35 at its lowest and $9.54 at its peak.
During the past year, Aura Biosciences(AURA) stock moved between $4.35 at its lowest and $9.54 at its peak.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.